Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Smiths Medical ASD Inc. recalls CADD-Solis Ambulatory Infusion Pumps

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
CADD-Solis Ambulatory Infusion Pumps, with software versions before v4.3, may have the following issues:1. Upstream Occlusion, 2. Stop and Power Keys Unresponsive, 3. Manual Mode Air Detector, 4. Single Bubble Air Detection, 5. Error Codes Not Displayed at Power Up, 6. Audible Alarm, 7. Low Sensitivity Air in Line Detection Threshold, 8. PharmGuard Server Password. Smiths Medical corrected many of the issues included in this notification in previous software updates and the corrections were carried forward into all subsequent software releases. Please ensure you have the most recent CADD software (v4.3 - 2023) installed on your pumps.
Products
  • CADD-Solis Ambulatory Infusion Pumps
Where it was sold

Worldwide

Nationwide

Barcodes
306105860353371061058603295010610586035548306105860353441061058603535730610586035368106105860353951061058603540110610586035418106105860354251061058603544910610586035456106105860354631061058603548710610586035494106105860318543061058603551130610586035528106105860355311061058603394010610586033933
Units affected
9284 units
About this recall
CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.